3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
23
Peritoneal Neoplasms
15
Fallopian Tube Neoplasms
10
Colorectal Neoplasms
8
Stomach Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Neoplasms
3
Sarcoma
2
Rhabdomyosarcoma
2
Recurrence
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Brain Neoplasms
2
Appendiceal Neoplasms
2
Adrenocortical Carcinoma
2
Adenoma, Islet Cell
2
Wilms Tumor
1
Retroperitoneal Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Postoperative Complications
1
Peritoneal Cavity Cancer
1
Peritoneal Cancer
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neuroblastoma
1
Interventions
Cisplatin
28
Pemetrexed
24
pembrolizumab
12
Nivolumab
10
Carboplatin
9
atezolizumab
7
Gemcitabine
7
Cyclophosphamide
7
durvalumab
6
Drug Therapy
6
sodium thiosulfate
5
Radiotherapy, Intensity-Modulated
5
tremelimumab
4
aldesleukin
4
Radiotherapy
4
Interleukin-2
4
sargramostim
3
Vinorelbine
3
Platinum
3
Photochemotherapy
3
Ipilimumab
3
Doxorubicin
3
Dihematoporphyrin Ether
3
Chemotherapy, Adjuvant
3
Cerebral Decortication
3
vatalanib
2
regorafenib
2
niraparib
2
lenvatinib
2
cemiplimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mesothelioma, Malignant
×
Cytoreduction Surgical Procedures
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled